Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

RSS icon
Lower Costs More Transparency Act

House passes ‘landmark’ bill to juice healthcare price transparency

Bipartisan legislation intended to lower healthcare costs by lifting price transparency has made it through the U.S. House of Representatives.

Video interview with Richard Heller, MD, RSNA Board member, associate chief medical officer for health policy and communications, and national director of pediatric radiology at Radiology Partners, explains the impact of the 2024 Medicare cuts on radiology and what comes next. #RSNA #RSNZA23 #RSNA2023 #CMS #Radiology

Putting US radiology reimbursement cuts in context and what comes next

Richard Heller, MD, a member of the RSNA Board and associate CMO for Rad Partners, explains the impact of the 2024 Medicare cuts and what is at stake.

private equity in healthcare grassley whitehouse

Hospitals, firms interrogated by powerful senators

A heavyweight bipartisan duo in the U.S. Senate has begun grilling some for-profit healthcare providers and the private equity outfits that own them.

nurse burnout stock image

Washington nurses demand action over patient violence

Some 44 nurses from Seattle Children’s Hospital have signed onto a letter attributing the chaos to a “systemic crisis in pediatric mental health.”

Kit Crancer RBMA president on Medicare cuts RSNA 2023.

The impact of Medicare payment cuts on radiology and patient care access

RBMA President Kit Crancer said continued cuts will result in Medicare patients losing access to care when health systems and providers determine it is no longer economical.

phenylephrine FDA

Congressional group wants to grill FDA on recently rejected OTC decongestant

Three months after an FDA panel declared a popular cold remedy no more effective than a sugar pill, a House oversight panel wants to ask FDA leadership a pointed question: What took you so long?

Thumbnail

UnitedHealth faces lawsuit over AI algorithm that allegedly denied care to elderly patients

A lawsuit in federal court claims an AI algorithm used by the insurer systematically denied elderly patients’ claims for extended care.

CVD deaths have increased dramatically, undoing years of progress

The COVID-19 pandemic undid years and years of progress in terms of preventing CVD-related deaths. What can be done to help reverse this trend once and for all? 

Displaying 345 - 352 of 3407

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.